Cost-effectiveness of aducanumab to prevent Alzheimer's disease progression at current list price.

Published in: Alzheimer's & dementia (New York, N. Y.) (2022)

Aducanumab is not cost-effective at the estimated price of $56,000 even under ideal circumstances in which it completely halts AD progression.

Keyphrases